Evgen Pharma (GB:TCF) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
TheraCryf plc, specializing in oncology and neuropsychiatry drug development, will release its interim results for the first half of 2024 on November 28. The company, which trades on AIM under the ticker TCF, invites current and potential investors to a live presentation on the same day, providing an opportunity for engagement and questions.
For further insights into GB:TCF stock, check out TipRanks’ Stock Analysis page.